about
Exercise training and rehabilitation in pulmonary arterial hypertension: rationale and current data evaluation.Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service.Impact of pre-diabetes on heart transplant outcomes in patients with advanced heart failure.Coronary Computed Tomography (CT) Angiography as a Predictor of Cardiac and Noncardiac Vascular Events in Asymptomatic Type 2 Diabetics: A 7-Year Population-Based Cohort Study.Therapeutic angiogenesis in critical limb ischemia.Brown adipose tissue: research milestones of a potential player in human energy balance and obesity.Lipid-lowering therapies, glucose control and incident diabetes: evidence, mechanisms and clinical implications.Cardiac Computed Tomography Angiographic Findings as Predictors of Late Heart Failure in an Asymptomatic Diabetic Cohort: An 8-Year Prospective Follow-Up Study.The 894G Allele of the Endothelial Nitric Oxide Synthase 3 (eNOS) is Associated with Atrial Fibrillation in Chronic Systolic Heart Failure.Identification and characterization of severe familial hypercholesterolemia in patients presenting for cardiac catheterization.Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology.Impact of Diabetes Mellitus on Long-Term Mortality in Patients Presenting for Coronary Angiography.Contemporary evaluation of the causes of cardiac tamponade: Acute and long-term outcomes.Endothelial nitric oxide synthase polymorphism and prognosis in systolic heart failure patients.Single measurement of serum N-terminal pro-brain natriuretic peptide: the best predictor of long-term mortality in patients with chronic systolic heart failure.The association between obesity, mortality and filling pressures in pulmonary hypertension patients; the "obesity paradox".Joint impact of body mass index and physical capacity on mortality in patients with systolic heart failure.Epstein-Barr virus-associated pericarditis and pericardial effusion: case report and diagnostic aspects.Impact of diabetes and early revascularization on the need for late and repeat procedures.Influence of Body Mass Index on Long-Term Survival After Cardiac Catheterization.An Intervention to Reduce the Time Interval Between Hospital Entry and Emergency Coronary Angiography in Patients with ST-Elevation Myocardial Infarction.Risk score model for predicting mortality in advanced heart failure patients followed in a heart failure clinic.Clinical features and outcomes of severe, very severe, and extreme hypertriglyceridemia in a regional health service.Prognostic impact of abdominal fat distribution and cardiorespiratory fitness in asymptomatic type 2 diabetics.Comparison of body mass index and body surface area as outcome predictors in patients with systolic heart failure.Clinical Features and Gaps in the Management of Probable Familial Hypercholesterolemia and Cardiovascular Disease.Absence of the α(2c)-adrenoceptor Del322-325 allele is associated with increased mortality in patients with chronic systolic heart failure.The prognostic value of exercise testing: Exercise capacity, hemodynamic response, and cardio-metabolic risk factors.Serum levels of microRNAs in patients with heart failure.Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term RegistryCharacterization of Coronary Artery Disease in Young Adults and Assessment of Long-term OutcomesCoronary angiography in the very old: impact of diabetes on long-term revascularization and mortalityPrimary prevention in high-risk dyslipidemic patients without an established cardiovascular disease: Undertreatment and rationale for lipid-lowering therapySmall fiber neuropathy due to isolated vasculitis of the peripheral nervous systemMortality rates and modes of death in heart failure patients with reduced versus preserved systolic functionLow cardiorespiratory fitness and coronary artery calcification: Complementary cardiovascular risk predictors in asymptomatic type 2 diabeticsA novel approach to monitoring pulmonary congestion in heart failure: initial animal and clinical experiences using remote dielectric sensing technologyResting heart rate and measures of effort-related cardiac autonomic dysfunction predict cardiovascular events in asymptomatic type 2 diabetesPlaque Morphology as Predictor of Late Plaque Events in Patients With Asymptomatic Type 2 Diabetes: A Long-Term Observational StudyLipid-lowering therapy with PCSK9-inhibitors in the real-world setting: Two-year experience of a regional lipid clinic
P50
Q30662612-972712A9-0E25-456F-836C-2230BE05B9FFQ31161044-6633DF57-2879-4566-A2E9-04C029B17FC1Q34509957-E56DB28B-3C2E-451E-822B-0B39A4BFB2A9Q37076136-15C1CE27-349B-48EA-B7A1-9660996BCB47Q37142832-28CC4234-3090-4F28-9DF0-D746ECC0E05AQ38117251-888A268D-1325-4197-BB27-A80E7BE2B9D6Q38222135-8A1EEE74-208A-4358-94D4-172F2B5C3D0CQ38619761-24D77E70-2160-4260-B748-0F74A7E07B54Q38790603-6196CA19-9C39-4A81-9B2F-38D61038818FQ39129463-31CCBD11-D9FE-4E0E-A080-FE402DD3F2FAQ39752065-4BF59D60-9A52-4613-B40D-6AEFD62E0759Q40329135-980C3E4A-A318-4926-9566-82DA2DC99B4BQ40705737-245471AA-06F0-4B98-82DC-6E21A8E90307Q41007336-287A9549-2E19-4595-B184-DBF04A197EA3Q43885457-73C6717D-31E1-4F19-BD8E-A3E336825DA8Q44901183-3091B8D9-4CAB-41E6-B3E7-4006E257BD51Q45053467-F5BCC559-4AE6-4D05-968D-53DED73B8681Q45422680-2B218C88-19DE-4921-901B-2412FE59F0E9Q48103622-DEF43BA7-C5AA-4D79-970B-6332A0E1BEC8Q50086923-4DC5B328-CBCE-440A-AEF2-07FE2BCFC19BQ50261354-0386252C-C980-40EB-B968-80FB991BC475Q51321567-1BAD7759-6081-45C3-B91A-7C4F2DF16B46Q52568922-AF0D069F-0188-4123-90C5-BA623D61B5DBQ53058940-CCF51003-A473-4AF0-83F9-3FCA86A8BCA3Q53644658-B139FA42-271C-432F-8CC2-1DBB6DBF07DCQ53701233-78C1EB5F-F2BB-4DFD-863F-D9DEB186C32AQ54280951-2CB9E19B-826D-4047-8407-F0E275FE933AQ54325278-0CA095B8-A09E-412B-B247-B4243D50724CQ54336789-07B11DA8-D97E-454A-9A69-DE25DBDE4CBFQ57462406-FC21F265-90E5-4A0B-8F0F-67805550C02EQ57487319-31F122C1-0B91-4E45-B4A1-D8C8E5EF81FDQ64251833-99C217CA-9AC4-4843-909E-1497EB56DDEDQ79349577-0C390A56-41BB-4F4F-A288-378197158A12Q79847954-7174AAB4-4CC0-43B4-AF23-3E4B132DF249Q83215365-1A5B0ACB-FA8F-408A-B60E-C8065E207254Q85481361-8917D8A3-B480-449A-9E53-DBE032E39912Q85957707-F01F123A-7454-45E3-8C54-5B13CECBA14AQ86969370-247C5BA6-DD25-4C68-8DB2-AEE0180DD837Q88737799-B6BFCE34-5EE1-4619-9845-95EBAD9A7EF5Q88973062-DCBEC48E-8038-420A-AA68-882EFF9D5951
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Barak Zafrir
@ast
Barak Zafrir
@en
Barak Zafrir
@es
Barak Zafrir
@nl
Barak Zafrir
@sl
type
label
Barak Zafrir
@ast
Barak Zafrir
@en
Barak Zafrir
@es
Barak Zafrir
@nl
Barak Zafrir
@sl
prefLabel
Barak Zafrir
@ast
Barak Zafrir
@en
Barak Zafrir
@es
Barak Zafrir
@nl
Barak Zafrir
@sl
P106
P1153
55945029800
P31
P496
0000-0002-2391-8397